S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
US consumer sentiment falls slightly as outlook for inflation worsens
Faced with possibly paying for news, Google removes links to California news sites for some users
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
US consumer sentiment falls slightly as outlook for inflation worsens
Faced with possibly paying for news, Google removes links to California news sites for some users
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
US consumer sentiment falls slightly as outlook for inflation worsens
Faced with possibly paying for news, Google removes links to California news sites for some users
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
US consumer sentiment falls slightly as outlook for inflation worsens
Faced with possibly paying for news, Google removes links to California news sites for some users
NASDAQ:THRX

Theseus Pharmaceuticals (THRX) Stock Price, News & Analysis

$4.06
0.00 (0.00%)
(As of 02/14/2024)
Today's Range
$4.06
$4.06
50-Day Range
$4.06
$4.08
52-Week Range
$2.05
$12.37
Volume
N/A
Average Volume
592,167 shs
Market Capitalization
$179.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.75
THRX stock logo

About Theseus Pharmaceuticals Stock (NASDAQ:THRX)

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors. The company also develops THE-349, a fourth-generation selective epidermal growth factor receptor inhibitor to address C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. As of February 14, 2024, Theseus Pharmaceuticals, Inc. operates as a subsidiary of Concentra Biosciences, LLC.

THRX Stock Price History

THRX Stock News Headlines

Theseus Pharmaceuticals Announces Closing of Tender Offer
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
Theseus Pharma To Acquire Concentra Biosciences For $4.05/Shr In Cash
Theseus Pharmaceuticals Inc THRX
See More Headlines
Receive THRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:THRX
Fax
N/A
Employees
38
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.75
High Stock Price Target
$9.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+66.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-50,610,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$5.36 per share

Miscellaneous

Free Float
23,575,000
Market Cap
$179.57 million
Optionable
Optionable
Beta
3.98
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

THRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Theseus Pharmaceuticals stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theseus Pharmaceuticals in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" THRX shares.
View THRX analyst ratings
or view top-rated stocks.

What is Theseus Pharmaceuticals' stock price target for 2024?

4 brokers have issued 1-year price targets for Theseus Pharmaceuticals' shares. Their THRX share price targets range from $4.00 to $9.00. On average, they expect the company's share price to reach $6.75 in the next year. This suggests a possible upside of 66.3% from the stock's current price.
View analysts price targets for THRX
or view top-rated stocks among Wall Street analysts.

How have THRX shares performed in 2024?

Theseus Pharmaceuticals' stock was trading at $4.05 at the beginning of the year. Since then, THRX shares have increased by 0.2% and is now trading at $4.06.
View the best growth stocks for 2024 here
.

How were Theseus Pharmaceuticals' earnings last quarter?

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) issued its quarterly earnings results on Monday, November, 15th. The company reported ($5.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $4.93.

When did Theseus Pharmaceuticals IPO?

Theseus Pharmaceuticals (THRX) raised $150 million in an IPO on Thursday, October 7th 2021. The company issued 10,000,200 shares at $14.00-$16.00 per share.

How do I buy shares of Theseus Pharmaceuticals?

Shares of THRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:THRX) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners